Loading…

Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement‐mediated acute inflammation

SUMMARY Complement activation plays a relevant role in the development of tissue damage under inflammatory conditions, and clinical and experimental observations emphasize its contribution to inflammatory vasculitides. Statins have recently been shown to reduce cardiovascular morbidity independently...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental immunology 2004-02, Vol.135 (2), p.186-193
Main Authors: FISCHETTI, F., CARRETTA, R., BOROTTO, G., DURIGUTTO, P., BULLA, R., MERONI, P. L., TEDESCO, F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SUMMARY Complement activation plays a relevant role in the development of tissue damage under inflammatory conditions, and clinical and experimental observations emphasize its contribution to inflammatory vasculitides. Statins have recently been shown to reduce cardiovascular morbidity independently of plasma cholesterol lowering and in vitro studies support a direct anti‐inflammatory action of these drugs. The aim of this study was to verify the in vivo effect of fluvastatin on complement‐mediated acute peritoneal inflammation. The effect of oral treatment with fluvastatin was investigated in normo‐cholesterolaemic rats that received intraperitoneal injection of either yeast‐activated rat serum (Y‐act RS) or lipopolysaccharide to induce peritoneal inflammation monitored by the number of PMN recruited in peritoneal fluid washes. In addition, vascular adherence and extravasation of leucocytes were evaluated by direct videomicroscopy examination on mesentery postcapillary venules topically exposed to Y‐act RS. The number of PMN in the peritoneal washes of rats treated with fluvastatin was 38% lower than that of untreated animals (P 
ISSN:0009-9104
1365-2249
DOI:10.1111/j.1365-2249.2003.02358.x